0001183740-22-000159.txt : 20220901 0001183740-22-000159.hdr.sgml : 20220901 20220901144327 ACCESSION NUMBER: 0001183740-22-000159 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220901 DATE AS OF CHANGE: 20220901 EFFECTIVENESS DATE: 20220901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRIGHT MINDS BIOSCIENCES INC. CENTRAL INDEX KEY: 0001827401 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457729 FILM NUMBER: 221220649 BUSINESS ADDRESS: STREET 1: 19 VESTRY STREET CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 6474072515 MAIL ADDRESS: STREET 1: 19 VESTRY STREET CITY: NEW YORK STATE: NY ZIP: 10013 D 1 primary_doc.xml X0708 D LIVE 0001827401 BRIGHT MINDS BIOSCIENCES INC. 19 VESTRY STREET NEW YORK NY NEW YORK 10013 6474072515 BRITISH COLUMBIA, CANADA 1210954 BC Ltd. None Corporation true 2019 Ian McDonald 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Director Chief Executive Officer and President Ryan Cheung 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Chief Financial Officer Alan Kozikowski 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Revati Shreeniwas 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Chief Medical Officer Jeremy Fryzuk 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Jan Torleif Pedersen 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Director Interim Chief Science Officer Nils Bottler 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Biotechnology Decline to Disclose 06b false 2022-08-30 true true true true true Compensation Warrants, each exercisable into units of the Issuer ("Units"). Each Unit consisting of one common share and one common share purchase warrant ("Warrant"). false 0 220329 0 220329 Total Offering Amount represents exercise price of Units (91,158 x $1.071*|C$1.40) and underlying Warrants (91,158 x $1.346*|C$1.76). There is no assurance these securities be exercised prior to expiry on August 30, 2024. *C$1=$0.7648 @ Aug 30, 2022 false 1 0 0 0 false BRIGHT MINDS BIOSCIENCES INC. /s/ Ryan Cheung Ryan Cheung Chief Financial Officer 2022-09-01